Makolab (MLB) fair value: what the stock is really worth
As of Oct 23, 2026: fair value (intrinsic value) of Makolab stock PLN 15.75, price PLN 7.80, upside +101.9%, quality 69 out of 100. Rating: strongly undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Fair value above price?Yes
Good quality?Yes
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 24, 2026.
How to read this chart
60‑month range 2.42 PLN – 9.85 PLN · fair‑value band 11.81 PLN – 19.69 PLN · the 7.80 PLN price screens below the 15.75 PLN fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 24, 2026.
Follow Makolab in your weekly email
Every Wednesday you see whether Makolab is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
MakoLab Spólka Akcyjna operates as a digital solutions company in Poland.
Show moreShow less
It provides consulting services for customer experience, business, organization, data, operations, and technology and security; product design, including business, user experience, and solution architecture design services; and delivery services, consisting of proof of concept, minimum viable product, and target solution delivery services.
The company also provides DevOps, support and maintenance, and custom SEO services. In addition, it offers cloud computing, disaster recovery, managed IT, hosting and co-location, and network solutions services.
The company offers its solutions to automotive, finance and insurance, real estate, e-commerce, and other sectors. It exports its products. The company was founded in 1989 and is headquartered in Lódz, Poland.
Stock analysis
Makolab (MLB) currently trades at 7.80 PLN, while our model-based Fair Value estimate is 15.75 PLN, implying the stock looks roughly 50.5% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 21.06 PLN per share, and 20 of the 26 models we run sit above the 7.80 PLN price.
Bear case: the Dividend Discount group reads lowest at 2.09 PLN, and 6 of the 26 models stay below the price. Data coverage for this calculation is medium.
Scenario range: 11.81 PLN (bear) to 19.69 PLN (bull), the price of 7.80 PLN sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 69/100 (solid quality), in the Technology sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Makolab reported revenue of 77.9M PLN in FY2025 versus 54.5M PLN in FY2021, a compound +9.4%/yr. Reported net income was 3.9M PLN in FY2025, compounding +22.6%/yr from FY2021.
Key figures
Market cap 54.5M PLN (≈ $13.9M) Micro · P/E ratio 10.9 · P/S ratio 0.55 · EPS (TTM) 0.6854 PLN · Dividend yield 2.0% · Net margin 5.0% · Return on equity 2,757% · Return on assets (EBIT) 12.1%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 49 out of 100 (low confidence).
What moves the price
The share trades about 21% below its 52-week high and 64% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Technology peers we cover trades at 10% fair-value upside, at 102%, MLB screens cheaper than that median.
Fair Value models
Bear11.81 PLNFair Value 15.75 PLNBull19.69 PLN
Price 7.80 PLN · Upside +101.9%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (0.5596 PLN per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.86/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+3.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.9%
Start year 2020 (pandemic). Over 10 years: +13.6% a year
Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.6%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−1.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year−3.8%
Dividend (yield on the price)2.0%
Profit margin 2015 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.18% → 8%
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−12.8%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Poland: IMF forecast 3.1% a year to 2030, 4.6% from 2016 to 2025) that is about −15.4% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Software & IT Services · 37 stocks
Beats the industry median on 6/9 measures
Overall it ranks above its industry peers.
Valuation
Quality Score69 · Top 25%
Fair Value upside+101.9% · Above median
Profitability
Return on assets8.2% · Top 25%
Net margin (12 months)5.0% · Below median
Operating margin (12 months)0.0% · Below median
Growth and dividend
Revenue growth (quarter YoY)0.0% · Below median
Dividend yield (12 months)2.0% · Above median
Valuation Multiplesvs Software & IT Services median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Makolab Fair Value". https://www.fairvalue-calculator.com/stock/MLB
Frequently asked questions
Is Makolab (MLB) overvalued or undervalued?
As of Oct 24, 2026, our model estimates a fair value of 15.75 PLN versus a price of 7.80 PLN, about +102% upside (undervalued).
What is the fair value of MLB?
Our model-based fair value for Makolab is 15.75 PLN (as of Oct 24, 2026), built from audited fundamentals. The current price: 7.80 PLN.
What is the quality score of MLB?
Makolab has a Quality Score of 69/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Makolab (MLB)?
Our model-based price target is the fair value of 15.75 PLN (as of Oct 24, 2026) from 26 valuation models. Cautious scenario 11.81 PLN, optimistic scenario 19.69 PLN. It is a calculation from audited fundamentals, not an analyst target.
What is the Makolab stock forecast for 2026?
Our models put fair value at 15.75 PLN, about +102% upside versus a price of 7.80 PLN (undervalued). Cautious scenario 11.81 PLN, optimistic scenario 19.69 PLN. The calculation is refreshed regularly with new filings.
Does Makolab pay a dividend?
Makolab currently shows a dividend yield of 2.01% relative to its recent price (as of Oct 24, 2026).
What growth is priced into Makolab (MLB)?
For today's price to be fair in a discounted-cash-flow model, Makolab would have to grow free cash flow by -12.8 % per year for five years (discount rate 10.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +9.9 % per year. As of Oct 24, 2026.
What discount rate (WACC) does the fair value of MLB use?
Our models discount Makolab at 10.6 %: a base by market capitalisation (nano), country premium for Poland. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Makolab that is -12.8 % per year a year over ten years, using the same discount rate (10.6 %) and the same formula as our fair value.
How much growth has Makolab (MLB) delivered so far?
Over the past 5 years revenue at Makolab grew +9.9 % a year. The price currently implies -12.8 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Makolab (MLB) growing?
The median revenue growth in the sector is +10.8 % a year. That is the yardstick for the growth priced into Makolab (-12.8 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Makolab (MLB)?
The free-cash-flow yield on the price is 12.53 %: that much free cash flow Makolab produces per unit of market value. When it exceeds the discount rate of our models (10.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Makolab (MLB)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Makolab it is 15.75 PLN per share (as of Oct 24, 2026), against a price of 7.80 PLN. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Makolab stock overvalued or undervalued in 2026?
As of Oct 24, 2026, MLB trades below its calculated fair value: price 7.80 PLN, fair value 15.75 PLN, a gap of about +102% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of MLB?
No. The price is what the market pays today (7.80 PLN); the fair value is what the company's own numbers justify (15.75 PLN). For Makolab the two are 7.95 PLN per share apart. That gap is exactly why we show both numbers side by side.
How much is Makolab worth?
The market values Makolab at about 54.5M PLN (market capitalisation, as of Oct 24, 2026). Per share that is 7.80 PLN; our models calculate a fair value of 15.75 PLN per share.
What do the bullish and bearish scenarios say about MLB?
Our models span a range for Makolab: cautious scenario 11.81 PLN, base 15.75 PLN, optimistic 19.69 PLN per share (as of Oct 24, 2026, price 7.80 PLN). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of MLB?
Makolab trades at a price-to-earnings ratio of 10.9 (as of Oct 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 15.75 PLN is built from several models across several years. Other multiples: P/B 0.4.
How far is MLB from its 52-week high?
Makolab trades at 7.80 PLN, about 21% below its 52-week high of 9.85 PLN and 64% above the low of 4.77 PLN (as of Oct 23, 2026). Distance from the high says nothing about value: that is what the fair value of 15.75 PLN is for.
Which stocks are comparable to Makolab?
From the same area (Technology) we also value KINX, Inc, Wemade Co, Gabia Inc, Hancom Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Makolab stock attractive at the current price?
The data as of Oct 24, 2026: price 7.80 PLN, calculated fair value 15.75 PLN (+102%), Quality Score 69/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of MLB calculated?
We run Makolab through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 15.75 PLN, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 12.3 % above its aggregate fair value. Makolab currently trades 50 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Makolab (MLB)?
The closing price on Oct 23, 2026 was 7.80 PLN. Our model-based fair value is 15.75 PLN, about +102% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Makolab right now?
The price is below even our cautious bear case (11.81 PLN). The market is more pessimistic than our downside scenario. Solid quality (69/100) at a price below fair value, the discount is the argument here, not the business quality.
Key figures of Makolab
How large is the market capitalisation of Makolab (MLB)?
The market capitalisation of Makolab is 54.5M PLN (≈ $13.9M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Makolab (MLB)?
The price-to-sales ratio of Makolab is 0.55 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Makolab (MLB)?
Earnings per share at Makolab are 0.6854 PLN (price ÷ EPS = P/E 10.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Makolab (MLB)?
The dividend yield of Makolab is 2.0% (payout 22.9%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Makolab (MLB)?
The net margin of Makolab is 5.0% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Makolab (MLB)?
The return on equity (ROE) of Makolab is 2,757% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Makolab (MLB)?
On an EBIT basis the return on assets of Makolab is 12.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
Free · no account needed
Watch Makolab in the live analysis
One click puts Makolab on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
